Neuronal Migration Depends on Intact Peroxisomal Function in Brain and in Extraneuronal Tissues

Journal of Neuroscience

Volumn 23, Issue 30, 2003, Pages 9732-9741

  Janssen, Anneleen ^a   Gressens, Pierre ^b   Grabenbauer, Markus ^c   Baumgart, Eveline ^c,f   Schad, Arno ^c   Vanhorebeek, Ilse ^a   Brouwers, Annelies ^a   Declercq, Peter E ^a   Fahimi, Dariush ^c   Evrard, Philippe ^b   Schoonjans, Luc ^d   Collen, Désiré ^e   Carmeliet, Peter ^e   Mannaerts, Guy ^a   Van Veldhoven, Paul ^a   Baes, Myriam ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Thromb X   (Belgium)

^e DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^f JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

DHA; Neuronal migration; Peroxisome; Plasmalogen; VLCFA; Zellweger syndrome

Indexed keywords

DOCOSAHEXAENOIC ACID; PLASMALOGEN; VERY LONG CHAIN FATTY ACID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL DEATH; CELL MIGRATION; CONTROLLED STUDY; FATTY ACID OXIDATION; LIVER; METABOLISM; MOUSE; NEOCORTEX; NERVE CELL; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; ZELLWEGER SYNDROME;

EID: 0242440918     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-30-09732.2003     Document Type: Article

References (41)

1. Antonenkov VD, Van Veldhoven PP, Waelkens E, Mannaerts GP (1997) Substrate specificities of 3-oxoacyl-CoA thiolase A and sterol carrier protein 2/3-oxoacyl-CoA thiolase purified from normal rat liver peroxisomes. J Biol Chem 272:26023-26031.
2. Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M, Evrard P, Fahimi D, Declercq PE, Collen D, Van Veldhoven PP, Mannaerts GP (1997) A mouse model for Zellweger syndrome. Nat Genet 17:49-57.
3. Baes M, Dewerchin M, Janssen A, Collen D, Carmeliet P (2002a) Generation of Pex5-IoxP mice allowing the conditional elimination of peroxisomes. Genesis 32:177-178.
4. Baes M, Gressens P, Huyghe S, De Nys K, Qi C, Jia Y, Mannaerts GP, Evrard P, Van Veldhoven PP, Declercq PE, Reddy JK (2002b) The neuronal migration defect in mice with Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal β-oxidation. J Neuropathol Exp Neurol 61:368-374.
5. Baumgart E, Völkl A, Hashimoto T, Fahimi HD (1989) Biogenesis of peroxisomes: immunocytochemical investigation of peroxisomal membrane proteins in proliferating rat liver peroxisomes and in catalase-negative membrane loops. J Cell Biol 108:2221-2231.
6. Baumgart E, Vanhorebeek I, Grabenbauer M, Borgers M, Declercq P, Fahimi HD, Baes M (2001) Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 159:1477-1494.
7. Behar TN, Li Y-X, Tran HT, Ma W, Dunlap V, Scott C, Barker JL (1996) GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms. J Neurosci 16:1808-1818.
8. Datta NS, Wilson GN, Hajra AK (1984) Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. N Engl J Med 311:1080-1083.
9. Evrard P, Caviness VS, Prats-Vinas J, Lyon G (1978) The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis based upon cytoarchitectonic analysis. Acta Neuropathol (Berl) 41:109-117.
10. Fahimi HD (1969) Cytochemical localization of peroxidatic activity of catalase in rat hepatic microbodies (peroxisomes). J Cell Biol 43:275-288.
11. Fan C-Y, Pan J, Chu R, Lee D, Kluckman KD, Usuda N, Singh I, Yeldandi AV, Rao MS, Maeda N, Reddy JK (1996) Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J Biol Chem 271:24698-24710.
12. Faust PL, Hatten ME (1997) Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J Cell Biol 139:1293-1305.
13. Fleenor DE, Kaufman RE (1993) Characterization of the DNase I hypersensitive site 3′ of the human β globin gene domain. Blood 81:2781-2790.
14. Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, Zimmermann F, Nave K-A (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50:829-843.
15. Godbout R, Ingram R, Tilghman SM (1986) Multiple regulatory elements in the intergenic region between the α-fetoprotein and albumin genes. Mol Cell Biol 6:477-487.
16. Gould SJ, Raymond GV, Valle D (2001) The peroxisome biogenesis disorders. In: The metabolic and molecular bases of inherited disease (Scriver CR, Beaudet AL, Valle D, Sly WS, eds), pp 3181-3217. New York: McGraw-Hill.
17. Grabenbauer M, Fahimi HD, Baumgart E (2001) Detection of peroxisomal proteins and their mRNAs in serial sections of fetal and newborn mouse organs. J Histochem Cytochem 49:155-164.
18. Gressens P (2000) Mechanisms and disturbances of neuronal migration. Pediatr Res 48:725-730.
19. Gressens P, Baes M, Leroux P, Lombet A, Van Veldhoven P, Janssen A, Vamecq J, Marret S, Evrard P (2000) Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction. Ann Neurol 48:336-343.
20. Hammer RE, Krumlauf R, Camper SA, Brinster RL, Tilghman SM (1987) Diversity of alpha-fetoprotein gene expression in mice is generated by a combination of separate enhancer elements. Science 235:53-58.
21. Hatten ME (1999) Central nervous system neuronal migration. Annu Rev Neurosci 22:511-539.
22. Huyghe S, Casteels M, Janssen A, Meulders L, Mannaerts GP, Declercq PE, Van Veldhoven PP, Baes M (2001) Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse. Biochem J 353:673-680.
23. Janssen A, Baes M, Gressens P, Mannaerts GP, Declercq P, Van Veldhoven PP (2000) Docosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient mice. Lab Invest 80:31-35.
24. 32P-labeled substrate. Clin Chem 40:946-947.
25. Kobayashi T, Shinnoh N, Kondo A, Yamada T (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232:631-636.
26. Komuro H, Rakic P (1992) Selective role of N-type calcium channels in neuronal migration. Science 257:806-809.
27. Li X, Baumgart E, Morrell JC, Jimenez-Sanchez G, Valle D, Gould SJ (2002) PEX11β deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol Cell Biol 22:4358-4365.
28. Lu J-F, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 94:9366-9371.
29. Moser HW, Moser AB (1996) Very long-chain fatty acids in diagnosis, pathogenesis, and therapy of peroxisomal disorders. Lipids 31:141-144.
30. Pikaart MJ, Recillas-Targa F, Felsenfeld G (1998) Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev 12:2852-2862.
31. Potts W, Tucker D, Wood H, Martin C (2000) Chicken β-globin 5′HS4 insulators function to reduce variability in transgenic founder mice. Biochem Biophys Res Commun 273:1015-1018.
32. Powers JM (1995) The pathology of peroxisomal disorders with pathogenic considerations. J Neuropath Exp Neurol 54:710-719.
33. Purdue PE, Lazarow PB (2001) Peroxisome biogenesis. Annu Rev Cell Dev Biol 17:701-752.
34. Rakic P, Cameron RS, Komuro H (1994) Recognition, adhesion, transmembrane signaling and cell motility in guided neuronal migration. Neurobiology 4:63-69.
35. Subramani S, Koller A, Snyder WB (2000) Import of peroxisomal matrix and membrane proteins. Annu Rev Biochem 69:399-418.
36. Takahashi T, Nowakowski RS, Caviness VS (1992) BrdU as an S-phase marker for quantitative studies of cytokinetic behaviour in the murine cerebral ventricular zone. J Neurocytol 21:185-197.
37. Terlecky SR, Fransen M (2000) How peroxisomes arise. Traffic 1:465-473.
38. Van Veldhoven PP, Van Rompuy P, Fransen M, de Béthune B, Mannaerts GP (1994) Large-scale purification and further characterization of rat-pristanoyl-CoA oxidase. Eur J Biochem 222:795-801.
39. Walsh CA (1999) Genetic malformations of the human cerebral cortex. Neuron 23:19-29.
40. Yamaguchi M, Saito H, Suzuki M, Mori K (2000) Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice. Dev Neurosci 11:1991-1996.
41. Zimmerman L, Lendahl U, Cunningham M, McKay R, Parr B, Gavin B, Mann J, Vassileva G, McMahon A (1994) Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 12:11-24.